DOCSLIB.ORG

AY Thesis Version 16 4 05 Final Printed for Binding

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
AY Thesis Version 16 4 05 Final Printed for Binding Fluorescent cannabinoids: Strategies towards the synthesis of fluorescently labelled CB2 receptor ligands Andrew Stephen Yates BPharm MRPharmS AMRSC School of Pharmacy, The University of Nottingham Nottingham UK Thesis submitted to the University of Nottingham for the degree of Doctor of Philosophy November 2004 1 “A chemist dabbling in his lab Felt his project was a little drab So embarked to discover fluorescent weed Citing a greater scientific need Soon had friends with glowing lips Funded his life on their grateful tips Checked his spectra, in disbelief When his friends got no relief He made an error in his reaction That gave his friends no satisfaction In desperation he hid away Improving his creation day by day His project done, his girlfriend’s plea Was to write it up as a PhD This is what I submit to you To read, to marvel, to hold as true” - A. S. Yates 2 Table of contents Abstract ...........................................................................................................................i Acknowledgements ........................................................................................................ii Abbreviations ................................................................................................................iii 1. Introduction............................................................................................................1 1.1 Fluorescent labelled ligands as a tool to study G-protein coupled receptors.2 1.1.1 Principles of fluorescence ......................................................................4 1.1.2 Fluorescent techniques ...........................................................................5 1.1.2.1 Confocal microscopy..........................................................................5 1.1.2.2 Single molecule detection..................................................................6 1.1.2.2.1 Fluorescence correlation spectroscopy.........................................7 1.1.2.2.2 Other single molecule detection techniques.................................8 1.1.2.3 High throughput screening applications.............................................9 1.2 Cannabis.......................................................................................................10 1.2.1 Historical overview of cannabis...........................................................10 1.2.2 Therapeutic use of cannabis .................................................................14 1.2.2.1 Multiple Sclerosis.............................................................................15 1.2.2.2 Analgesia..........................................................................................16 1.2.2.3 Nausea and vomiting........................................................................17 1.2.2.4 Appetite modification.......................................................................17 1.2.2.5 Other therapeutic areas.....................................................................18 1.3 The cannabis receptors.................................................................................20 1.3.1 GPCR receptors....................................................................................20 1.3.2 Gi/o cell signalling.................................................................................23 1.3.3 The CB1 receptor system......................................................................25 1.3.4 The CB2 receptor system......................................................................28 1.3.4.1 The distribution of the CB2 receptor................................................29 1.3.4.2 Immune functions of the CB2 receptor.............................................32 1.3.4.3 In-vitro bioassay systems .................................................................33 1.3.4.3.1 Binding assays ............................................................................33 1.3.4.3.2 [35S] Guanosine-5’-O-(3-thiotriphosphate) ([35H] GTP-g-S) binding........................................................................................34 1.3.4.3.3 Inhibition of cyclic AMP production.........................................34 1.3.4.3.4 Practical difficulties....................................................................34 1.3.4.4 Therapeutic indications of the CB2 receptor....................................35 1.3.4.4.1 Pain.............................................................................................35 1.3.4.4.2 Multiple Sclerosis.......................................................................35 1.3.4.4.3 Immunomodulation....................................................................36 1.3.4.4.4 Cancer.........................................................................................36 1.4 Ligands for the cannabis receptors...............................................................38 1.4.1 Nomenclature .......................................................................................39 1.4.2 Classical cannabinoids .........................................................................41 1.4.2.1 The side chain...................................................................................42 1.4.2.2 The phenolic group...........................................................................43 1.4.2.3 The 9-methyl group ..........................................................................44 1.4.2.4 CB2 selective classical cannabinoids................................................46 1.4.3 Non-classical cannabinoids..................................................................47 1.4.3.1 CB2 selective Non-Classical Cannabinoids......................................50 1.4.4 Arachidonic acid derivatives................................................................52 3 1.4.5 Pyrazole cannabinoids..........................................................................53 1.4.5.1 CB2 selective pyrazoles....................................................................54 1.4.6 Indole based cannabinoids ...................................................................56 1.4.6.1 Modeling studies on indoles.............................................................58 1.4.6.2 CB2 selective indoles........................................................................60 1.4.7 Japan Tobacco ligands .........................................................................63 1.5 Research Aims..............................................................................................66 2 Fluorescent CB2 ligand based on a modification to the benzamide ring of a Japan Tobacco compound. .....................................................................................................67 2.1 Background to designing a GPCR fluorescent ligand..................................67 2.1.1 Fluorescent adenosine agonist ligands .................................................67 2.1.1.1 Synthetic strategy used for fluorescent adenosine agonists .............71 2.1.2 Fluorescent serotonin ligands...............................................................73 2.1.1 Summary of the design and synthesis requirements of fluorescent ligands ..................................................................................................75 2.2 Designing a fluorescent cannabinoid CB2 ligand.........................................76 2.2.1 Selection of a suitable CB2 ligand........................................................77 2.2.2 Selection of a suitable site upon JTE2-6 for conjugation.....................77 2.2.3 Determining a suitable linker ...............................................................78 2.2.4 Selection of a fluorophore....................................................................79 2.2.5 Synthetic strategy.................................................................................81 2.3 Chemistry results..........................................................................................84 2.3.1 Conjugation with amine reactive dyes.................................................87 2.4 Pharmacology results ...................................................................................90 2.5 Use of Dansyl-JTE2-6 and BODIPY-JTE2-6 in fluorescence confocal microscopy. ......................................................................................................91 2.6 Discussion....................................................................................................92 2.7 Conclusions ..................................................................................................96 3 Molecular modelling of the CB2 receptor and docking of JTE2-6 ......................97 3.1 Computational modelling a of G-protein coupled receptor .........................97 3.1.1 Crystal structure template.....................................................................98 3.1.2 Sequence alignment..............................................................................98 3.1.3 Energy minimisation and molecular dynamics ..................................100 3.1.4 Ligand docking...................................................................................103 3.2 Previous modelling of the CB2 receptor.....................................................104 3.2.1 Mutational analysis ............................................................................104 3.2.2 Molecular modelling studies ..............................................................108 3.2.2.1 Results from previous CB2 models ................................................108
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2005/0065361A1 Deshmukh Et Al
    US 2005OO65361A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2005/0065361A1 Deshmukh et al. (43) Pub. Date: Mar. 24, 2005 (54) PROCESS FOR PREPARING ALKYLARYL (22) Filed: Sep. 22, 2003 CHLOROFORMATES Publication Classification (76) Inventors: Abdul Rakeeb Abdul Subhan Deshmukh, Maharashtra (IN); Vikas (51) Int. Cl." ........................... C07C 69/74; C07C 69/96 Kalyanrao Gumaste, Maharashtra (IN) (52) U.S. Cl. .............................................................. 558/280 Correspondence Address: (57) ABSTRACT NIXON & VANDERHYE, PC The present invention discloses an improved method for the 1100 N GLEBE ROAD preparation of alky/aryl chloroformates directly from alco 8TH FLOOR hols and triphosgene. This method is simple, mild and ARLINGTON, VA 22201-4714 (US) efficient avoids use of hazardous phosgene. It can be used for the preparation of various aryl as well as alkyl chlorofor (21) Appl. No.: 10/665,410 mates in excellent yields. US 2005/0065361 A1 Mar. 24, 2005 PROCESS FOR PREPARING ALKYLARYL Maligres, K. C. Nicolau, W. Wrasidio Bioorg. Med. Chem. CHLOROFORMATES Lett. 1993, 3, 1051. (c) D. C. Horwell, J. Hughes, J. Hunter, M. C. Pritchard, R. S. Richardson, E. Roberts, G. N. FIELD OF THE INVENTION Woodruff J. Med. Chem., 1991, 34, 404 and tertiary amines as base H. Eckert, B. Forster, Angew. Chem. Int. Ed. Engl., 0001. The present invention relates to a process for 1987,26,894). Hydroquinone is also used in the preparation preparing alkyl/aryl chloroformates. More particularly, the of chloroformates from triphosgene G. Van den Mooter, C. present invention relates to a process for preparing com Samyn, R. Kinget Int. J. Pharm., 1993, 97, 133).
    [Show full text]
  • Chapter 6 Industrial Applications of Multicomponent Reactions (Mcrs)
    University of Groningen Innovative multicomponent reactions and their use in medicinal chemistry Zarganes Tzitzikas, Tryfon IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2017 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Zarganes Tzitzikas, T. (2017). Innovative multicomponent reactions and their use in medicinal chemistry. University of Groningen. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 24-09-2021 CHAPTER 6 INDUSTRIAL APPLICATIONS OF MULTICOMPONENT REACTIONS (MCRS) Chapter contained in the Rodriguez-Bonne book Stereoselectve Multple Bond-Forming Transformatons in Organic Synthesis 2015 by John Wiley & Sons, Inc. Tryfon Zarganes – Tzitzikas, Ahmad Yazbak, Alexander Dömling Chapter 6 INTRODUCTION Multcomponent reactons (MCRs) can be defned as processes in which three or more reactants introduced simultaneously are combined through covalent bonds to form a single product, regardless of the mechanisms and protocols involved.[1] Many basic MCRs are name reactons, for example, Ugi,[2] Passerini,[3] van Leusen,[4] Strecker,[5] Hantzsch,[6] Biginelli,[7] or one of their many variatons.
    [Show full text]
  • The Preparation of Certain Organic Chloroformates and Carbonates
    Brigham Young University BYU ScholarsArchive Theses and Dissertations 1947-04-01 The preparation of certain organic chloroformates and carbonates Robert E. Brailsford Brigham Young University - Provo Follow this and additional works at: https://scholarsarchive.byu.edu/etd BYU ScholarsArchive Citation Brailsford, Robert E., "The preparation of certain organic chloroformates and carbonates" (1947). Theses and Dissertations. 8175. https://scholarsarchive.byu.edu/etd/8175 This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected], [email protected]. THE PREPARATI OH OF CERTAI N 0RG.1NIC CHLOROFORJ.'\Ll.TES AND CARBON T Thesis ubmitted to the Department of Chemistry Brigham Young University ~ .. ... "') .~ . ~ . "'). ... .. .. .. .. , ... .. ... : : ....: . ..-. ~ ..·.: : ..: ...• : ·.. ~ . : ,.. .~ : :. : ·: : ··.... ; ~ : ·. : : .: . : . : : : ••• .... •." •,.r_·: -••• ~ .... In Parti a l Fulfillment of the Re~uirements for the Degree Master of cienoe 147143 by Robert E. Brailsford .tipril 1947 This Thesis by Robert E. Brailsford is accepted in its present farm by the Department of Chemistry of Brigham Young University as satisfying the ·rhesis requirement for the degree of Master of Science. PREFACE flhile working for the Hooker Electrochemical Company of Niagara Falls , New York , from April 3 , 1943 , to January 30 , 1946 , the writer became interested in organic chloroformates and. carbonates , an interest instigated by requests from B. F . Goodrich Company for a number of samples . fter returning to Brigham Young University that preliminary interest was revived and the experi - mental work of this thesis was performed. under the direction of Dr . Charles ' . :Maw and Professor Joseph K.
    [Show full text]
  • Carbonate and Benzyl Benzotriazol-L-Yl Carbonate. Now
    70 Bull. Korean Chem. Soc., Vol. 7, No. 1, 1986 Sunggak Kim and Heung Chang t-Butyl Benzotriazol-l-yl Carbonate and Benzyl Benzotriazol-l-yl Carbonate. Now Reactive Amino Protective Reagents for t-Butoxy carbonylation and Benzyloxycarbonylation of Amines and Amino Acids Sunggak Kim* and Heung Chang Department of Chemistry, Korea Advanced Institute of Science and Technology, Seoul 131, Received September24,1985 New amino protective reagents, /-butyl benzotriazol-l-yl carbonate and benzyl benzotriazol-l-yl carbonate, for t~ butoxycarbonylation and benzyloxycarbonylation of amines and amino acids have been developed. f-Butyl benzotriazol-1 -yl carbonate reacts rapidly and cleanly with various amines and amino acids to afford N-Boc amines and N-Boc amino acids in high yields and benzyl benzotriazol-l-yl carbonate is also found to be very effective in the benzyloxycarbonylation of amino acids. Introduction a solution of an equimolar amount of 1-hydroxybenzotriazole and pyridine in methylene chloride to the solution of an ex­ The Z-butoxycarbonyl (Boc) group is one of the most im­ cess amount of phosgene in toluene under cooling portant amino protective groups along with benzyloxycarbonyl (-20~ 一 10°C). The resulting product was relatively unstable (Cbz) group in peptide synthesis.1 Since /-butyl chloroformate and was mainly decomposed to 1-hydroxybenzotriazole dur­ is only fairly stable above 10°C,2 it is difficult to is이 ate t- ing workup with cold water. Thus； benzotriazol-l-yl chlorofor­ butyl chloroformate as a pure form in high yields. Thus, con­ mate was used in a crude form. BBC could be prepared readily siderable efforts have been devoted to the development of a by the reaction of benzotriazol-l-yl chloroformate with variety of useful and reliable reagents for the preparation of equimolar amounts of f나 mtyl alcohol and pyridine in N-Boc amino acids during last 30 years.1 methylene chloride at room temperature for 2 h (eq.
    [Show full text]
  • Benzyl Chloroformate (CHLOROFORMIC ACID, BENZYL ESTER)
    Rev B Benzyl Chloroformate (CHLOROFORMIC ACID, BENZYL ESTER) C8H7O2Cl Molecular Weight = 170.6 CAS# 501‐53‐1 SPECIFICATIONS Assay: 98.% min. Color (APHA): 50 max. Benzyl Alcohol: 0.1% max. Hydrogen Chloride: 0.1% max. Benzyl Chloride: 1.5% max. Phosgene: 0.1% max. Dibenzyl Carbonate: 0.5% max. Iron: 1.5 PPM max. PHYSICAL PROPERTIES Appearance: Clear liquid free of visible contaminants BP: Decomposes at elevated temperature Odor: Pungent Density: 1.195 ‐1.22 MP/Range: ‐30°C Flash Point: 126°C NOTICE: The technical information and suggestions for use made herein are based on VanDeMark’s research and experience and are believed to be reliable, but such information and suggestions do not constitute a warranty, and no patent liability can be assumed. This publication is not to be taken as a license to operate under or infringe on any patents. Since VanDeMark has no control over the conditions under which the product is transported, stored, handled, used or applied, buyer must determine for himself by preliminary tests or otherwise, the suitability of the product for his purposes. VanDeMark’s liability on any basis is limited to the price of the product used. The information in this bulletin supersedes all previously issued bulletins on the subject matter covered. VanDeMark Benzyl Chloroformate APPLICATIONS SPILLS AND DISPOSAL Benzyl Chloroformate is a reactive chemical intermediate Use personal protective equipment (see MSDS). used in the synthesis of pharmaceutical and agrochemical Evacuate personnel to safe areas. Dike far ahead of products. It is used as a reagent in peptide synthesis to liquid spill for later disposal.
    [Show full text]
  • Synthesis, Utility and Medicinal Importance of 1,2- & 1,4
    RSC Advances REVIEW View Article Online View Journal | View Issue Synthesis, utility and medicinal importance of 1,2- & 1,4-dihydropyridines Cite this: RSC Adv.,2017,7, 2682 Vivek K. Sharmaa and Sunil K. Singh*b Dihydropyridine (DHP) is among the most beneficial scaffolds that have revolutionised pharmaceutical research with unprecedented biological properties. Over the years, metamorphosis of easily accessible 1,2- and 1,4-dihydropyridine (1,4-DHP) intermediates by synthetic chemists has generated several drug molecules and natural products such as alkaloids. The 1,4-dihydropyridine (1,4-DHP) moiety itself is the main fulcrum of several approved drugs. The present review aims to collate the literature of 1,2- and the 1,4-DHPs relevant to synthetic and medicinal chemists. We will describe various Received 6th October 2016 methodologies that have been used for the synthesis of this class of compounds, including the Accepted 14th November 2016 strategies which can furnish enantiopure DHPs, either by asymmetric synthesis or by chiral resolution. DOI: 10.1039/c6ra24823c We will also elaborate the significance of DHPs towards the synthesis of natural products of medicinal www.rsc.org/advances merit. Creative Commons Attribution 3.0 Unported Licence. 1. Introduction oxidation–reduction reactions, has made the 1,4-DHP core even more lucrative. Perhaps less studied in the past, the potential of Arthur Hantzsch added one of the most valuable scaffolds to the 1,2-dihydropyridines has recently been explored as a critical toolbox of medicinal chemists, reporting the synthesis of scaffold for the synthesis of alkaloids and other drugs. 1,2-DHPs dihydropyridine (DHP) in 1882.
    [Show full text]
  • Synthetic Methods for Biologically Relevant Organofluorine Compounds
    Scholars' Mine Doctoral Dissertations Student Theses and Dissertations Spring 2007 Synthetic methods for biologically relevant organofluorine compounds Meher Perambuduru Follow this and additional works at: https://scholarsmine.mst.edu/doctoral_dissertations Part of the Chemistry Commons Department: Chemistry Recommended Citation Perambuduru, Meher, "Synthetic methods for biologically relevant organofluorine compounds" (2007). Doctoral Dissertations. 2286. https://scholarsmine.mst.edu/doctoral_dissertations/2286 This thesis is brought to you by Scholars' Mine, a service of the Missouri S&T Library and Learning Resources. This work is protected by U. S. Copyright Law. Unauthorized use including reproduction for redistribution requires the permission of the copyright holder. For more information, please contact [email protected]. t+/ E. : i :_~· f 9;?.::; SYNTHETIC METHODS FOR BIOLOGICALLY RELEVANT ORGANOFLUORINE COMPOUNDS by MEHERPERAMBUDURU A DISSERTATION Presented to the Faculty ofthe Graduate School of the UNIVERSITY OF MISSOURI-ROLLA In Partial Fulfillment of the Requirements for the Degree DOCTOR OF PHILOSOPHY m CHEMISTRY 2007 V. PRAKASH REDDY EKKEHARD SINN ~~ NURANERCAL 111 ABSTRACT This thesis describes novel synthetic methodologies for the synthesis of biologically relevant organofluorine compounds. Chapter 1 outlines the recent trends in this area and our synthetic procedures for the preparation of the gem-difluoromethylene analogues of the biologically active dipeptides, carnosine and carcinine. Synthesis of the latter compounds has been achieved using the fluorinated building block approach. Thus reaction of gem-difluoro-~­ alanine with histidine methyl ester dihydrochloride or histamine dihydrochloride using N­ benzyloxycarbonyl (N-Cbz) protecting strategy and EDCVHOBt peptide coupling protocol gave the gem-difluorinated version of the peptides carnosine and carcinine respectively. The gem­ Difluoro analogue of ~-alanine was prepared from a fluorine synthon, ethyl bromodifluoroacetate using Reforrnatsky reaction conditions.
    [Show full text]
  • Documents Numérisés Par Onetouch
    19 ORGANISATION AFRICAINE DE LA PROPRIETE INTELLECTUELLE 51 8 Inter. CI. C07D 471/04 (2018.01) 11 A61K 31/519 (2018.01) N° 18435 A61P 29/00 (2018.01) A61P 31/12 (2018.01) A61P 35/00 (2018.01) FASCICULE DE BREVET D'INVENTION A61P 37/00 (2018.01) 21 Numéro de dépôt : 1201700355 73 Titulaire(s): PCT/US2016/020499 GILEAD SCIENCES, INC., 333 Lakeside Drive, 22 Date de dépôt : 02/03/2016 FOSTER CITY, CA 94404 (US) 30 Priorité(s): Inventeur(s): 72 US n° 62/128,397 du 04/03/2015 CHIN Gregory (US) US n° 62/250,403 du 03/11/2015 METOBO Samuel E. (US) ZABLOCKI Jeff (US) MACKMAN Richard L. (US) MISH Michael R. (US) AKTOUDIANAKIS Evangelos (US) PYUN Hyung-jung (US) 24 Délivré le : 27/09/2018 74 Mandataire: GAD CONSULTANTS SCP, B.P. 13448, YAOUNDE (CM). 45 Publié le : 15.11.2018 54 Titre: Toll like receptor modulator compounds. 57 Abrégé : The present disclosure relates generally to toll like receptor modulator compounds, such as diamino pyrido [3,2 D] pyrimidine compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR-8), and methods of making and using them. O.A.P.I. – B.P. 887, YAOUNDE (Cameroun) – Tel. (237) 222 20 57 00 – Site web: http:/www.oapi.int – Email: [email protected] 18435 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application claims priority to U.S. Provisional Application Nos. 62/128397, filed March 4, 2015, and 62/250403, filed November 3, 2015, both of which are incorporated herein in their entireties for all purposes.
    [Show full text]
  • Thesis of Substituted Hydroxyguanidines and Related Systems
    University of Bath PHD Synthesis of substituted hydroxyguanidines and related systems. Peace, Alastair Award date: 1983 Awarding institution: University of Bath Link to publication Alternative formats If you require this document in an alternative format, please contact: [email protected] General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 04. Oct. 2021 TO MY FAMILY AND JACQUELINE ^ __ 2 8 MAR 1933 Synthesis of Substituted Hydroxyguanidines and Related Systems. Submitted by Alastair Peace for the degree of Ph.D of the University of Bath 1983. COPYRIGHT Attention is drawn to the fact that copyright of this thesis rests with its author. This copy of the thesis has been supplied on condition that anyone who consults i t is understood to recognise that its copyright rests with its author and that no quotation from the thesis, and no information derived from i t may be published with­ out the prior written consent of the author.
    [Show full text]
  • Part I the Synthesis of Proline-Containing Polypeptides Part Ii Chemical Shift Nonequivalence in 2,4-Dinitrophenyl Sulfenamides
    University of New Hampshire University of New Hampshire Scholars' Repository Doctoral Dissertations Student Scholarship Spring 1975 PART I THE SYNTHESIS OF PROLINE-CONTAINING POLYPEPTIDES PART II CHEMICAL SHIFT NONEQUIVALENCE IN 2,4-DINITROPHENYL SULFENAMIDES THOMAS DAVID HARRIS Follow this and additional works at: https://scholars.unh.edu/dissertation Recommended Citation HARRIS, THOMAS DAVID, "PART I THE SYNTHESIS OF PROLINE-CONTAINING POLYPEPTIDES PART II CHEMICAL SHIFT NONEQUIVALENCE IN 2,4-DINITROPHENYL SULFENAMIDES" (1975). Doctoral Dissertations. 1082. https://scholars.unh.edu/dissertation/1082 This Dissertation is brought to you for free and open access by the Student Scholarship at University of New Hampshire Scholars' Repository. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of University of New Hampshire Scholars' Repository. For more information, please contact [email protected]. INFORMATION TO USERS This material was produced from a microfilm copy of the original document. While the most advanced technological means to photograph and reproduce this document have been used, the quality is heavily dependent upon the quality of the original submitted. The following explanation of techniques is provided to help you understand markings or patterns which may appear on this reproduction. 1. The sign or “target" for pages apparently lacking from the document photographed is “Missing Page(s)". If it was possible to obtain the missing page(s) or section, they are spliced into the film along with adjacent pages. This may have necessitated cutting thru an image and duplicating adjacent pages to insure you complete continuity. 2. When an image on the film is obliterated with a large round black mark, it is an indication that the photographer suspected that the copy may have moved during exposure and thus cause a blurred image.
    [Show full text]
  • American Chemical Society Division of Organic Chemistry 243Rd ACS National Meeting, San Diego, CA, March 25-29, 2012
    American Chemical Society Division of Organic Chemistry 243rd ACS National Meeting, San Diego, CA, March 25-29, 2012 A. Abdel-Magid, Program Chair; R. Gawley, Program Chair SUNDAY MORNING Ralph F. Hirschmann Award in Peptide Chemistry: Symposium in Honor of Jeffery W. Kelly D. Huryn, Organizer; D. Huryn, Presiding Papers 1-4 Biologically-Related Molecules and Processes A. Abdel-Magid, Organizer; T. Altel, Presiding Papers 5-16 New Reactions and Methodology A. Abdel-Magid, Organizer; N. Bhat, Presiding Papers 17-28 Asymmetric Reactions and Syntheses A. Abdel-Magid, Organizer; D. Leahy, Presiding Papers 29-39 Material, Devices, and Switches A. Abdel-Magid, Organizer; S. Thomas, Presiding Papers 40-49 SUNDAY AFTERNOON James Flack Norris Award in Physical Organic Chemistry: Symposium to Honor Hans J. Reich G. Weisman, Organizer; G. Weisman, Presiding Papers 50-53 Understanding Additions to Alkenes D. Nelson, Organizer; D. Nelson, Presiding Papers 54-61 Biologically-Related Molecules and Processes A. Abdel-Magid, Organizer; B. C. Das, Presiding Papers 62-73 New Reactions and Methodology A. Abdel-Magid, Organizer; T. Minehan, Presiding Papers 74-85 Asymmetric Reactions and Syntheses A. Abdel-Magid, Organizer; A. Mattson, Presiding Papers 86-97 Material, Devices, and Switches A. Abdel-Magid, Organizer; Y. Cui, Presiding Papers 98-107 SUNDAY EVENING Material, Devices, and Switches, Molecular Recognition, Self-Assembly, Peptides, Proteins, Amino Acids, Physical Organic Chemistry, Total Synthesis of Complex Molecules R. Gawley, Organizer Papers 108-257 MONDAY MORNING Herbert C. Brown Award for Creative Research in Synthetic Organic Chemistry: Symposium in Honor of Jonathan A. Ellman S. Sieburth, Organizer; S. Sieburth, Presiding Papers 258-261 Playing Ball: Molecular Recognition and Modern Physical Organic Chemistry C.
    [Show full text]
  • A Step-Economic and One-Pot Access to Chiral Cα-Tetrasubstituted Α
    Chemical Science EDGE ARTICLE View Article Online View Journal | View Issue A step-economic and one-pot access to chiral Ca- tetrasubstituted a-amino acid derivatives via Cite this: Chem. Sci., 2020, 11, 4801 a bicyclic imidazole-catalyzed direct All publication charges for this article have been paid for by the Royal Society enantioselective C-acylation† of Chemistry Mo Wang,ab Muxing Zhou,b Lu Zhang,b Zhenfeng Zhang *b and Wanbin Zhang *ab Ca-Tetrasubstituted a-amino acids are ubiquitous and unique structural units in bioactive natural products and pharmaceutical compounds. The asymmetric synthesis of these molecules has attracted a lot of attention, but a more efficient method is still greatly desired. Here we describe the first sequential four- step acylation reaction for the efficient synthesis of chiral Ca-tetrasubstituted a-amino acid derivatives from simple N-acylated amino acids via an auto-tandem catalysis using a single nucleophilic catalyst. The synthetic efficiency is improved via a direct enantioselective C-acylation; the methodology affords Creative Commons Attribution 3.0 Unported Licence. Received 11th February 2020 a the corresponding C -tetrasubstituted a-amino acid derivatives with excellent enantioselectivities (up to Accepted 24th April 2020 99% ee). This step-economic, one-pot, and auto-tandem strategy provides facile access to important DOI: 10.1039/d0sc00808g chiral building blocks, such as peptides, serines, and oxazolines, which are often used in medicinal and rsc.li/chemical-science synthetic chemistry. Introduction
    [Show full text]